Skip to content

Feasibility Study for Online Mindfulness for GAD

Feasibility and Acceptability of an Evidence-based Mindfulness Online Resources for Patients With Generalized Anxiety Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05059834
Enrollment
36
Registered
2021-09-28
Start date
2021-10-15
Completion date
2022-10-31
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Generalized

Brief summary

Method: . Forty patients with general anxiety disorder will be randomized in 1:1 ratio to the online resource plus usual care, and to usual care control group by stratified block randomization. Measurements including 7-item Generalized Anxiety Disorder questionnaire, 9-item Patient Health Questionnaire, Penn State Worry questionnaire, and Five Facet Mindfulness Questionnaire will be made at baseline and at 2-month. Rate of recruitment, drop out and website usage will be collected. All patients in the intervention arm will be interviewed to assess the clarity of the app and user experience. The scores between the two arms will be compared by t-test and the transcripts of the patient interviews will be analysed using thematic analysis

Interventions

BEHAVIORALonline mindfulness resources

a free mindfulness resource online for patients with general anxiety disorder

BEHAVIORALusual care

patient will continue to receive drug and advice from doctors and nurses for their anxiety disorder

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* received a diagnosis of GAD in the computerized record system (CMS) in Hong Kong hospital authority * score ≥10 on the 7-item Generalized Anxiety Disorder scale (GAD-7), signifying active moderate anxiety symptoms * used any website in prior 12 months * received stable dose of psychoactive medications in last 2 months

Exclusion criteria

* any diagnosed psychotic disorder * diagnosis of dementia * any diagnosed substance abuse disorder (except smoking) * active suicidal ideation (score ≥1 on 9-item Patient Health Questionnaire * had regular mindfulness meditation practice in last 6 months or had participated in MBSR/MBCT course

Design outcomes

Primary

MeasureTime frameDescription
recruitment ratethrough study completion, an average of 1 yearrate of recruitment during the trial period
dropout ratethrough study completion, an average of 1 yearrate of dropout during the trial period

Secondary

MeasureTime frameDescription
7-item Generalized Anxiety Disorder questionnairebaseline and 2-montha validated questionnaire to measure anxiety symptoms. Possible score ranged from 0-21. the higher the score, the more severe the anxiety symptoms
9-item Patient Health Questionnairebaseline and 2-montha validated questionnaire to measure anxiety symptoms. Possible score ranged from 0-27. the higher the score, the more severe the depressive symptoms
Penn State Worry Questionnairebaseline and 2-montha validated questionnaire to measure worry. The possible score ranged from 16-80. the higher the score, the more severe the worries
Five Facet Mindfulness Questionnairebaseline and 2-montha validated questionnaire to measure mindfulness. The possible score ranged from 1-5. the higher the score, the more mindful the participants are

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026